| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―May―02 |
Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor |
Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez, Virgilio Bocanegra-García, Ana Verónica Martinez-Vazquez, Erick de Jesús de Luna-Santillana, Gerard Pujadas, Guadalupe Rojas-Verde, Edgar E. Lara-Ramírez, Gildardo Rivera |
| 2 |
[GO] |
2024―Mar―27 |
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection |
Maxim Lebedev, Aaron B. Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S. Lin, Kent J. Koster, Julian L. Leibowitz, Annelise E. Barron, Jeffrey D. Cirillo |
| 3 |
[GO] |
2024―Mar―18 |
Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation- and Immune-Related Pathways in T Lymphocytes from Patients with SARS-CoV-2 Infection with Pneumonia: Sex-Related Differences |
Donatas Stakišaitis, Linas Kapočius, Vacis Tatarūnas, Dovydas Gečys, Auksė Mickienė, Tomas Tamošuitis, Rasa Ugenskienė, Arūnas Vaitkevičius, Ingrida Balnytė, Vaiva Lesauskaitė |
| 4 |
[GO] |
2024―Feb―14 |
Silver Nanoparticles In Situ Synthesized and Incorporated in Uniaxial and Core-Shell Electrospun Nanofibers to Inhibit Coronavirus |
Camila F. de Freitas, Paulo R. Souza, Gislaine S. Jacinto, Thais L. Braga, Yara S. Ricken, Gredson K. Souza, Wilker Caetano, Eduardo Radovanovic, Clarice W. Arns, Mahendra Rai, Edvani C. Muniz |
| 5 |
[GO] |
2024―Feb―09 |
Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation-A Step toward Correct Dosing |
Dragana Milaković, Tijana Kovačević, Pedja Kovačević, Vedrana Barišić, Sanja Avram, Saša Dragić, Biljana Zlojutro, Danica Momčičević, Branislava Miljković, Katarina Vučićević |
| 6 |
[GO] |
2024―Feb―02 |
The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19 |
Miklós Bege, Anikó Borbás |
| 7 |
[GO] |
2024―Jan―29 |
Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (Salamandra salamandra) |
Ana Luisa A. N. Barros, Vladimir C. Silva, Atvaldo F. Ribeiro-Junior, Miguel G. Cardoso, Samuel R. Costa, Carolina B. Moraes, Cecília G. Barbosa, Alex P. Coleone, Rafael P. Simões, Wanessa F. Cabral, Raul M. Falcão, Andreanne G. Vasconcelos, Jefferson A. Rocha, Daniel D. R. Arcanjo, Augusto Batagin-Neto, Tatiana Karla S. Borges, João Gonçalves, Guilherme D. Brand, Lucio H. G. Freitas-Junior, Peter Eaton, Mariela Marani, Massuo J. Kato, Alexandra Plácido, José Roberto S. A. Leite |
| 8 |
[GO] |
2024―Jan―25 |
Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor |
Sebastjan Kralj, Marko Jukič, Miha Bahun, Luka Kranjc, Anja Kolarič, Milan Hodošček, Nataša Poklar Ulrih, Urban Bren |
| 9 |
[GO] |
2023―Dec―19 |
Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase |
Yuri V. Khramtsov, Alexey V. Ulasov, Tatiana N. Lupanova, Tatiana A. Slastnikova, Andrey A. Rosenkranz, Egor S. Bunin, Georgii P. Georgiev, Alexander S. Sobolev |
| 10 |
[GO] |
2023―Dec―18 |
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection |
Carla Zannella, Annalisa Chianese, Alessandra Monti, Rosa Giugliano, Maria Vittoria Morone, Francesco Secci, Giuseppina Sanna, Aldo Manzin, Anna De Filippis, Nunzianna Doti, Massimiliano Galdiero |
| 11 |
[GO] |
2023―Dec―12 |
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice |
Mohammad Suhail Khan, Virginie Jakob, Randhir Singh, Raju S. Rajmani, Sahil Kumar, Céline Lemoine, Harry Kleanthous, Rajesh P. Ringe, Patrice M. Dubois, Raghavan Varadarajan |
| 12 |
[GO] |
2023―Oct―25 |
Development and Evaluation of a Self-Nanoemulsifying Drug Delivery System for Sinapic Acid with Improved Antiviral Efficacy against SARS-CoV-2 |
Hani A. Alhadrami, Ahmed S.G. Srag El-Din, Hossam M. Hassan, Ahmed M. Sayed, Albaraa H. Alhadrami, Mostafa E. Rateb, Demiana M. Naguib |
| 13 |
[GO] |
2023―Aug―29 |
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection |
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, Miguel E. Quiñones-Mateu, Shyamal C. Das |
| 14 |
[GO] |
2023―Aug―02 |
SARS-CoV-2 Papain-like Protease Responsive ZnO/Daclatasvir-Loaded Chitosan/Gelatin Nanofibers as Smart Antimicrobial Medical Textiles: In Silico, In Vitro and Cell Studies |
Mohamed Hamdi, Akram M. Elkashlan, Mohamed A. Hammad, Isra H. Ali |
| 15 |
[GO] |
2023―Jul―20 |
What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine |
Urska Kamensek, Maja Cemazar, Simona Kranjc Brezar, Tanja Jesenko, Spela Kos, Katarina Znidar, Bostjan Markelc, Ziva Modic, Tilen Komel, Tim Gorse, Eva Rebersek, Helena Jakopic, Gregor Sersa |
| 16 |
[GO] |
2023―Jul―06 |
Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant |
Nirmitee Mulgaonkar, Haoqi Wang, Junrui Zhang, Christopher M. Roundy, Wendy Tang, Sankar Prasad Chaki, Alex Pauvolid-Corrêa, Gabriel L. Hamer, Sandun Fernando |
| 17 |
[GO] |
2023―May―31 |
Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43 |
Avinash Mali, Gianluigi Franci, Carla Zannella, Annalisa Chianese, Shubaash Anthiya, Ana M. López-Estévez, Alessandra Monti, Anna De Filippis, Nunzianna Doti, María José Alonso, Massimiliano Galdiero |
| 18 |
[GO] |
2023―May―23 |
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy |
Thelma Akanchise, Angelina Angelova |
| 19 |
[GO] |
2023―May―05 |
The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice |
Zhiyin An, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan, Yingjie Xu |
| 20 |
[GO] |
2023―Apr―28 |
Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination |
Ya-Xiu Feng, Huan Hu, Yu-Yuen Wong, Xi Yao, Ming-Liang He |
| 21 |
[GO] |
2023―Mar―22 |
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro |
Davide D’Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini |
| 22 |
[GO] |
2023―Mar―17 |
Plant-Derived Extracellular Vesicles as a Delivery Platform for RNA-Based Vaccine: Feasibility Study of an Oral and Intranasal SARS-CoV-2 Vaccine |
Margherita A. C. Pomatto, Chiara Gai, Federica Negro, Lucia Massari, Maria Chiara Deregibus, Cristina Grange, Francesco Giuseppe De Rosa, Giovanni Camussi |
| 23 |
[GO] |
2023―Mar―13 |
Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants |
Chee-Keng Mok, Yan Ling Ng, Bintou Ahmadou Ahidjo, Zhen Qin Aw, Huixin Chen, Yi Hao Wong, Regina Ching Hua Lee, Marcus Wing Choy Loe, Jing Liu, Kai Sen Tan, Parveen Kaur, De Yun Wang, Erwei Hao, Xiaotao Hou, Yong Wah Tan, Jiagang Deng, Justin Jang Hann Chu |
| 24 |
[GO] |
2023―Mar―10 |
An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice |
Sharon Vijayanand, Smital Patil, Ipshita Menon, Keegan Braz Gomes, Akanksha Kale, Priyal Bagwe, Mohammad N. Uddin, Susu M. Zughaier, Martin J. D’Souza |
| 25 |
[GO] |
2023―Mar―03 |
CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization |
Ana Isabel Sebastião, Daniela Mateus, Mylène A. Carrascal, Cátia Sousa, Luísa Cortes, Martin F. Bachmann, Anália do Carmo, Ana Miguel Matos, Maria Goreti F. Sales, Maria Teresa Cruz |
| 26 |
[GO] |
2023―Feb―16 |
Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial |
Ana Castro-Balado, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, Gema Barbeito-Castiñeiras, Ana Estany-Gestal, Rocío Trastoy-Pena, Miguel González-Barcia, Irene Zarra-Ferro, María Carmen del Río-Garma, Carlos Crespo-Diz, Olga Delgado-Sánchez, Francisco J. Otero-Espinar, Cristina Mondelo-García, Antonio Pose-Reino, Anxo Fernández-Ferreiro |
| 27 |
[GO] |
2023―Feb―15 |
Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19 |
Robert Szabo, Cristina Petrișor, Constantin Bodolea, Vlad Dobre, Sebastian Tranca, Simona Clichici, Iulia Szabo, Razvan Melinte, Teodora Mocan |
| 28 |
[GO] |
2023―Jan―30 |
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications |
Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, Vikas Sharma, Gaber El-Saber Batiha, Harpreet Kaur, Jashanpreet Singh, Deepak Kumar, Neha Sharma, Ajeet Kaushik, Raj Kumar |
| 29 |
[GO] |
2023―Jan―30 |
Effects of Dimerization, Dendrimerization, and Chirality in p-BthTX-I Peptide Analogs on the Antibacterial Activity and Enzymatic Inhibition of the SARS-CoV-2 PLpro Protein |
Natália Vitória Bitencourt, Gabriela Marinho Righetto, Ilana Lopes Baratella Cunha Camargo, Mariana Ortiz de Godoy, Rafael Victorio Carvalho Guido, Glaucius Oliva, Norival Alves Santos-Filho, Eduardo Maffud Cilli |
| 30 |
[GO] |
2023―Jan―20 |
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era |
Daniel Mieres-Castro, Freddy Mora-Poblete |
| 31 |
[GO] |
2023―Jan―19 |
Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511 |
Yue-Zhi Lee, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, Jang-Yang Chang, Huey-Kang Sytwu, Chiung-Tong Chen, Shiow-Ju Lee |
| 32 |
[GO] |
2022―Dec―29 |
Synthesis of Novel 1,3,4-Oxadiazole-Derived α-Aminophosphonates/α-Aminophosphonic Acids and Evaluation of Their In Vitro Antiviral Activity against the Avian Coronavirus Infectious Bronchitis Virus |
Shaima Hkiri, Marwa Mekni-Toujani, Elvan Üstün, Karim Hosni, Abdeljelil Ghram, Soufiane Touil, Ali Samarat, David Sémeril |
| 33 |
[GO] |
2022―Dec―19 |
Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells |
Mariarita Spampinato, Giuseppe Carota, Giuseppe Sferrazzo, Virginia Fuochi, Alfio Distefano, Simone Ronsisvalle, Federica Sipala, Rosario Giuffrida, Pio Maria Furneri, Michelino Di Rosa, Daniele Tibullo, Giovanni Li Volti, Ignazio Barbagallo |
| 34 |
[GO] |
2022―Nov―22 |
Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer |
Britney Niemann, Amanda Puleo, Conley Stout, Justin Markel, Brian A. Boone |
| 35 |
[GO] |
2022―Nov―22 |
Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus |
Anna-Liisa Kubo, Kai Rausalu, Natalja Savest, Eva Žusinaite, Grigory Vasiliev, Mihkel Viirsalu, Tiia Plamus, Andres Krumme, Andres Merits, Olesja Bondarenko |
| 36 |
[GO] |
2022―Nov―22 |
Formulation of SARS-CoV-2 Spike Protein with CpG Oligodeoxynucleotides and Squalene Nanoparticles Modulates Immunological Aspects Following Intranasal Delivery |
Hui-Min Ho, Chiung-Yi Huang, Chung-Hsiang Yang, Shih-Jen Liu, Hsin-Wei Chen, Guann-Yi Yu, Jen-Kun Chen, Tsung-Hsien Chuang, Ming-Hsi Huang |
| 37 |
[GO] |
2022―Nov―18 |
Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial |
Luca Cegolon, Giuseppe Mastrangelo, Enzo Emanuelli, Riccardo Camerotto, Giacomo Spinato, Daniele Frezza |
| 38 |
[GO] |
2022―Nov―07 |
Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations |
Helga K. Ruiz, Dolores R. Serrano, Lourdes Calvo, Albertina Cabañas |
| 39 |
[GO] |
2022―Nov―03 |
Potent Virucidal Activity In Vitro of Photodynamic Therapy with Hypericum Extract as Photosensitizer and White Light against Human Coronavirus HCoV-229E |
Beatriz Praena, Marta Mascaraque, Sabina Andreu, Raquel Bello-Morales, Edgar Abarca-Lachen, Valentina Rapozzi, Yolanda Gilaberte, Salvador González, José Antonio López-Guerrero, Ángeles Juarranz |
| 40 |
[GO] |
2022―Oct―24 |
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol |
Denis Nikolaevich Kisakov, Lyubov Alexandrovna Kisakova, Maria Borisovna Borgoyakova, Ekaterina Vladimirovna Starostina, Oleg Svyatoslavovich Taranov, Elena Konstantinovna Ivleva, Oleg Viktorovich Pyankov, Anna Vladimirovna Zaykovskaya, Dmitry Nikolaevich Shcherbakov, Andrey Pavlovich Rudometov, Nadezda Borisovna Rudometova, Natalia Vyacheslavovna Volkova, Vadim Nikolaevich Gureev, Alexander Alexeyevich Ilyichev, Larisa Ivanovna Karpenko |
| 41 |
[GO] |
2022―Oct―10 |
Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models |
Antimo Cutone, Luigi Rosa, Maria Carmela Bonaccorsi di Patti, Federico Iacovelli, Maria Pia Conte, Giusi Ianiro, Alice Romeo, Elena Campione, Luca Bianchi, Piera Valenti, Mattia Falconi, Giovanni Musci |
| 42 |
[GO] |
2022―Sep―28 |
Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression |
Khushwant S. Bhullar, Manal A. Nael, Khaled M. Elokely, Steven J. Drews, Jianping Wu |
| 43 |
[GO] |
2022―Sep―28 |
Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients |
Christiane Dings, Peter Meiser, Frank Holzer, Michael Flegel, Dominik Selzer, Eszter Nagy, Ralph Mösges, Jens Peter Klussmann, Thorsten Lehr |
| 44 |
[GO] |
2022―Sep―26 |
Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study |
Assem Ashimova, Askhat Myngbay, Sergey Yegorov, Baurzhan Negmetzhanov, Irina Kadyrova, Angelina Yershova, Ulpan Kart, Matthew S. Miller, Gonzalo Hortelano |
| 45 |
[GO] |
2022―Sep―21 |
2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19 |
Francesca Cantini, Emanuele Andreano, Ida Paciello, Veronica Ghini, Francesco Berti, Rino Rappuoli, Lucia Banci |
| 46 |
[GO] |
2022―Sep―08 |
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences |
Minela Aida Maranduca, Daniela Maria Tanase, Cristian Tudor Cozma, Nicoleta Dima, Andreea Clim, Alin Constantin Pinzariu, Dragomir Nicolae Serban, Ionela Lacramioara Serban |
| 47 |
[GO] |
2022―Sep―07 |
Reply to Zandi, M.; Soltani, S. Comment on “Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502” |
Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, Abdullah A. Alshehri, Majed O. Alawad, Salam Massadeh, Manal Alaamery, Ibrahim M. Aldeailej, Aref A. Alamri, Abdulwahab Z. Binjomah, Essam A. Tawfik |
| 48 |
[GO] |
2022―Sep―07 |
Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502 |
Milad Zandi, Saber Soltani |
| 49 |
[GO] |
2022―Aug―31 |
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients |
Verena Schöning, Felix Hammann |
| 50 |
[GO] |
2022―Aug―01 |
Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem |
Maria Sanz Codina, Milo Gatti, Carla Troisi, Giacomo Fornaro, Zeno Pasquini, Filippo Trapani, Andrea Zanoni, Fabio Caramelli, Pierluigi Viale, Federico Pea |
| 51 |
[GO] |
2022―Jul―22 |
The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b |
Yue-Zhi Lee, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, Jang-Yang Chang, Huey-Kang Sytwu, Chiung-Tong Chen, Shiow-Ju Lee |
| 52 |
[GO] |
2022―Jul―13 |
Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine |
Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, Elizabeth B. Lorentz, Jay T. Evans, David J. Burkhart |
| 53 |
[GO] |
2022―Jul―07 |
Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters |
Allegra Peletta, Eakachai Prompetchara, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Nongnaphat Yostrerat, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Jonathan Avaro, Leonard Krupnik, Antonia Neels, Kiat Ruxrungtham, Chutitorn Ketloy, Gerrit Borchard |
| 54 |
[GO] |
2022―Jul―01 |
Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome |
Monica-Carolina Villa-Hermosilla, Sofia Negro, Emilia Barcia, Carolina Hurtado, Consuelo Montejo, Mario Alonso, Ana Fernandez-Carballido |
| 55 |
[GO] |
2022―May―30 |
Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection |
Valentina Ruggiero, Rita P. Aquino, Pasquale Del Gaudio, Pietro Campiglia, Paola Russo |
| 56 |
[GO] |
2022―May―21 |
Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants |
Cong Liu, Nino Rcheulishvili, Zhigao Shen, Dimitri Papukashvili, Fengfei Xie, Ziqian Wang, Xingyun Wang, Yunjiao He, Peng George Wang |
| 57 |
[GO] |
2022―May―17 |
Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges |
Jasmin Hassan, Charlotte Haigh, Tanvir Ahmed, Md Jasim Uddin, Diganta B. Das |
| 58 |
[GO] |
2022―May―10 |
Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review |
Diego Fernández-Lázaro, Carlos Domínguez Ortega, Nerea Sánchez-Serrano, Fahd Beddar Chaib, David Jerves Donoso, Elena Jiménez-Callejo, Saray Rodríguez-García |
| 59 |
[GO] |
2022―Apr―19 |
Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2 |
Francisco Faísca, Vanessa Correia, Željko Petrovski, Luís C. Branco, Helena Rebelo-de-Andrade, Miguel M. Santos |
| 60 |
[GO] |
2022―Apr―14 |
Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate |
Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, Patrícia Gomes-Alves, Toon Stegmann, Mario Amacker, Paula M. Alves, Sylvain Fleury, António Roldão |
| 61 |
[GO] |
2022―Apr―14 |
Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems |
Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Waleed M. Hussein, Keith J. Chappell, Daniel Watterson, Paul R. Young, Mariusz Skwarczynski, Istvan Toth |
| 62 |
[GO] |
2022―Mar―14 |
Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study |
Ayman M. Al-Qaaneh, Fuad H. Al-Ghamdi, Sayed AbdulAzeez, J. Francis Borgio |
| 63 |
[GO] |
2022―Mar―07 |
COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments |
Ahmed Abdeen Hamed, Tamer E. Fandy, Karolina L. Tkaczuk, Karin Verspoor, Byung Suk Lee |
| 64 |
[GO] |
2022―Mar―01 |
Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs |
Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger, Julien Mayaux, Patrick Tilleul, Fadwa El Kouari, Hassane Sadou Yayé |
| 65 |
[GO] |
2022―Feb―28 |
Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic |
Nadezhda Ivanova, Yoana Sotirova, Georgi Gavrailov, Krastena Nikolova, Velichka Andonova |
| 66 |
[GO] |
2022―Feb―09 |
Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2 |
Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, Jong Hwan Song, Hyoung Rae Kim, Sunoh Kwon |
| 67 |
[GO] |
2022―Jan―28 |
Inhibition of Escherichia Virus MS2, Surrogate of SARS-CoV-2, via Essential Oils-Loaded Electrospun Fibrous Mats: Increasing the Multifunctionality of Antivirus Protection Masks |
Joana M. Domingues, Marta O. Teixeira, Marta A. Teixeira, David Freitas, Samira F. da Silva, Shafagh D. Tohidi, Rui D. V. Fernandes, Jorge Padrão, Andrea Zille, Carla Silva, Joana C. Antunes, Helena P. Felgueiras |
| 68 |
[GO] |
2022―Jan―10 |
In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19 |
Anirudh Pratap Singh Raman, Kamlesh Kumari, Pallavi Jain, Vijay Kumar Vishvakarma, Ajay Kumar, Neha Kaushik, Eun Ha Choi, Nagendra Kumar Kaushik, Prashant Singh |
| 69 |
[GO] |
2021―Dec―09 |
Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses |
Rosa Giugliano, Carmine Buonocore, Carla Zannella, Annalisa Chianese, Fortunato Palma Esposito, Pietro Tedesco, Anna De Filippis, Massimiliano Galdiero, Gianluigi Franci, Donatella de Pascale |
| 70 |
[GO] |
2021―Nov―03 |
Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections |
Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, Jong Hwan Song, Hyoung Rae Kim, Sunoh Kwon |
| 71 |
[GO] |
2021―Oct―25 |
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial |
Mustafa Erelel, Mert Kaskal, Ozlem Akbal-Dagistan, Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci, Merve Sinem Oguz, Aygun Qarayeva, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Gokben Sahin, Ali Yagiz Uresin, Ahmet Ogul Araman, Alpay Medetalibeyoglu, Tufan Tukek, Mustafa Oral Oncul, Ayca Yildiz-Pekoz |
| 72 |
[GO] |
2021―Oct―22 |
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19 |
Essa M. Saied, Yousra A. El-Maradny, Alaa A. Osman, Amira M. G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, Magdalena Piekutowska, Mohamed A. Abdel-Rahman, Bassem A. Balbool, Ahmed M. Abdel-Azeem |
| 73 |
[GO] |
2021―Oct―12 |
Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection |
Jiapeng Li, Shuhan Liu, Jian Shi, Hao-Jie Zhu |
| 74 |
[GO] |
2021―Oct―09 |
Can the Nasal Cavity Help Tackle COVID-19? |
Bissera Pilicheva, Radka Boyuklieva |
| 75 |
[GO] |
2021―Sep―29 |
Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era |
Piers J. Naughton, Mary Joyce, Marc Mac Giolla Eain, Andrew O’Sullivan, Ronan MacLoughlin |
| 76 |
[GO] |
2021―Sep―22 |
Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities |
Yong Xiang, Kenneth Chi-Yin Wong, Hon-Cheong So |
| 77 |
[GO] |
2021―Sep―22 |
Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity |
Serge Mignani, Xiangyang Shi, Andrii Karpus, Giovanni Lentini, Jean-Pierre Majoral |
| 78 |
[GO] |
2021―Sep―18 |
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment |
Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec |
| 79 |
[GO] |
2021―Sep―06 |
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro |
Linda Brunotte, Shuyu Zheng, Angeles Mecate-Zambrano, Jing Tang, Stephan Ludwig, Ursula Rescher, Sebastian Schloer |
| 80 |
[GO] |
2021―Aug―23 |
Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients |
Federico Romano, Salvatore D’Agate, Oscar Della Pasqua |
| 81 |
[GO] |
2021―Aug―16 |
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19 |
Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B. MacArthur, Hak-Kim Chan, Philip Chi Lip Kwok |
| 82 |
[GO] |
2021―Aug―02 |
Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized? |
Jessica M. Conway, Pia Abel zur Wiesch |
| 83 |
[GO] |
2021―Jul―14 |
Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection |
Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, Robin Polt, Julie G. Ledford, Heidi M. Mansour |
| 84 |
[GO] |
2021―Jul―07 |
Pre-Drawn Syringes of Comirnaty for an Efficient COVID-19 Mass Vaccination: Demonstration of Stability |
Francesca Selmin, Umberto M. Musazzi, Silvia Franzè, Edoardo Scarpa, Loris Rizzello, Patrizia Procacci, Paola Minghetti |
| 85 |
[GO] |
2021―May―31 |
A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19 |
Bárbara Costa, Nuno Vale |
| 86 |
[GO] |
2021―May―27 |
Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19 |
Kevin McCoy, Sateesh Gudapati, Lawrence He, Elaina Horlander, David Kartchner, Soham Kulkarni, Nidhi Mehra, Jayant Prakash, Helena Thenot, Sri Vivek Vanga, Abigail Wagner, Brandon White, Cassie S. Mitchell |
| 87 |
[GO] |
2021―May―24 |
Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone |
Monika Kadela-Tomanek, Maria Jastrzębska, Krzysztof Marciniec, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka |
| 88 |
[GO] |
2021―Apr―14 |
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics |
Dan-Yang Liu, Jia-Chen Liu, Shuang Liang, Xiang-He Meng, Jonathan Greenbaum, Hong-Mei Xiao, Li-Jun Tan, Hong-Wen Deng |
| 89 |
[GO] |
2021―Apr―07 |
Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles |
Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, Abdullah A. Alshehri, Majed O. Alawad, Salam Massadeh, Manal Alaamery, Ibrahim M. Aldeailej, Aref A. Alamri, Abdulwahab Z. Binjomah, Essam A. Tawfik |
| 90 |
[GO] |
2021―Apr―05 |
Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics |
Matteo Puccetti, Claudio Costantini, Maurizio Ricci, Stefano Giovagnoli |
| 91 |
[GO] |
2021―Apr―02 |
A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework |
Raul Pérez-Moraga, Jaume Forés-Martos, Beatriz Suay-García, Jean-Louis Duval, Antonio Falcó, Joan Climent |
| 92 |
[GO] |
2021―Mar―08 |
Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection |
Ana Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, Iria Varela-Rey, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, José Ramón Antúnez-López, Enrique José Bandín-Vilar, Raquel Sendón-García, Manuel Busto-Iglesias, Ana Rodríguez-Bernaldo de Quirós, Laura García-Quintanilla, Miguel González-Barcia, Irene Zarra-Ferro, Francisco J. Otero-Espinar, David Rey-Bretal, José Ramón Lago-Quinteiro, Luis Valdés-Cuadrado, Carlos Rábade-Castedo, María Carmen del Río-Garma, Carlos Crespo-Diz, Olga Delgado-Sánchez, Pablo Aguiar, Gema Barbeito-Castiñeiras, María Luisa Pérez del Molino-Bernal, Rocío Trastoy-Pena, Rossana Passannante, Jordi Llop, Antonio Pose-Reino, Anxo Fernández-Ferreiro |
| 93 |
[GO] |
2021―Feb―26 |
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities |
Milo Gatti, Fabrizio De De Ponti |
| 94 |
[GO] |
2021―Feb―26 |
Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies |
Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Aloafi, Ahmed Mostafa, Hani Z. Asfour, Ahmed A. Aldarmahi, Khaled M. Darwish, Tarek S. Ibrahim, Usama A. Fahmy |
| 95 |
[GO] |
2020―Dec―22 |
Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics |
Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier |
| 96 |
[GO] |
2020―Oct―05 |
COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics |
Saman Zafar, Muhammad Sohail Arshad, Sameen Fatima, Amna Ali, Aliyah Zaman, Elshaimaa Sayed, Ming-Wei Chang, Zeeshan Ahmad |
| 97 |
[GO] |
2020―May―11 |
MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice |
Hye-Jung Kim, Hye Won Kwak, Kyung Won Kang, Yoo-Jin Bang, Yu-Sun Lee, Hyeong-Jun Park, Jae-Yong Kim, Hyo-Jung Park, Kyung-Ah Hwang, Sang-Myeong Lee, Jae-Hwan Nam |
|
